TriSalus Thinks Its Drug/Device Strategy Can Optimize IO Regimens

 
• By Joseph Haas
  
Tissue
TriSalus hopes its delivery technology can yield better outcomes in liver, pancreatic cancers
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business